Tag:
MIT
Latest Headlines
Latest Headlines
MIT: Staggering cancer drugs can make them more effective
Researchers have come up with a method of staggering doses that has led to increased effectiveness of cancer drugs.
Charge-changing nanoparticles can help kill resistant bacteria
Researchers at MIT and Brigham and Women's Hospital may have found a nanotechnological solution to drug-resistant bacteria.
Crazy or creative? MIT finance whiz suggests a twist on CDOs for R&D
MIT finance engineering professor Andrew Lo caused a stir this week when he expounded on an unorthodox idea.
Novartis invests $550 million in flexible, modular processes at new plant
The company's long-term plan is to build a network of technology centers around the world.
Drug tackles Fragile X/autism symptoms in mice
Scientists at F. Hoffman-La Roche in Switzerland and the Picower Institute for Learning at the Massachusetts Institute of Technology believe they've found a new compound that reverses most Fragile X-related symptoms in adult mice.
MIT's Robert Langer turned out to be a pretty mellow guy
After years of writing about companies with technology that stemmed from the mind of legendary MIT professor Robert Langer, I finally got to chat with him on the phone.
MIT scientists tout first human data on drug-delivery chips
After overcoming bumps in the road and millions of dollars in development costs, venture-backed startup MicroCHIPS has evidence that its wirelessly controlled implant can release drugs into humans....
Microscopic booms: China, U.S. efforts mull explosive use of nanotech drug delivery
Two separate research efforts in China and the U.S. are exploring a rather dramatic use of nanotechnology to deliver drugs to their targets. Think of a microscopic explosion and that's where they're
Nanotech penetrates prostate cancer cells armed with chemo drugs
A team of Massachusetts researchers has figured out how to arm nanotech with chemotherapy drugs and successfully target it to hit prostate cancer cells, which absorbed the package well. Brigham and
Trout forges ahead on Novartis-MIT continuous processing effort
The Massachusetts Institute of Technology and drugmaker Novartis ( $NVS ) shook hands in 2007 on a 10-year, $65 million collaboration aimed at pulling pharma out of the batch age to capitalize on the
